newsfilter
← Latest News
GlobeNewswire·

Oculis to Participate in Upcoming September Investor Conferences

ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases